This looks promising.
A Rutgers study has found that a specific gene in cancerous prostate tumors indicates when patients are at high-risk for the cancer to spread, suggesting that targeting this gene can help patients live longer.........
This looks promising.
A Rutgers study has found that a specific gene in cancerous prostate tumors indicates when patients are at high-risk for the cancer to spread, suggesting that targeting this gene can help patients live longer.........
Nice find...Thanks for posting... a way to stop the spread, genetic targeting, treatment sensitizers, improved chemotherapy, immunotherapy, and new radiation therapies...working on ways to stop castrate resistance...there is hope, folks...
Keep fighting,
Fish
Here is a link to the study cited in the article.
nature.com/articles/s41467-...
Looks like MCTP-39 has real potential to slow tumor progression. From article:
Since we found that this inhibitor was well tolerated in vivo (Supplementary Fig. 4), we evaluated the effect of MCTP-39 on tumor growth of human prostate cells in vivo by establishing DU145 xenografts (Fig. 7c–f). We found that DU145 xenografts treated with MCTP-39 had a significant decrease in tumor volume (n = 14 vehicle-treated and n = 15 MCTP-39-treated; p < 0.001, two-way ANOVA; Fig. 7c, d).
Enough mouse testing, set up the phase 1.......
Fish
I will be keeping my eye out for CT's on this one. Hope it happens sooner than later.
Jim
Keep your eye on TAS 3681 and TRC 253 as well...... both are drugs that may block/stop wild or mutated AR leading to castrate resistance...3rd generation ADT.... Phase 1/2......The question will be can it stop it permanently, and if so...it could be a real game changer...
It may be my unconscious positivity (or ego) but I really believe I will make it to the cure one day. As long as they keep delaying progression I, and many of us, may make it to that cure. Thanks for the info.
Jim